Empirical second-line antimicrobial therapy in febrile neutropenic cancer patients

被引：0
|
作者：
Dong, W [1 ]
Liu, L [1 ]
Li, Y [1 ]
Ren, X [1 ]
Cheng, C [1 ]
Liu, S [1 ]
机构：
[1] Tsing Hua Univ, Affiliated Hosp 1, Beijing 100084, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8199
引用
收藏
页码：778S / 778S
页数：1
相关论文
共 50 条
  • [31] Second-line cannabis therapy in patients with epilepsy
    Braun, Erica
    Gualano, Francesca M.
    Siddarth, Prabha
    Segal, Eric
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 227
  • [32] EMPIRIC THERAPY IN THE MANAGEMENT OF FEBRILE NEUTROPENIC CANCER-PATIENTS
    ERKISI, MK
    KOKSAL, F
    AKAN, E
    BURGUT, R
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (01): : 23 - 28
  • [33] TIMENTIN IN COMBINATION WITH TOBRAMYCIN AS EMPIRICAL THERAPY IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    KRIEGER, O
    BERNHART, M
    PLOHOWICH, R
    NEMEC, H
    LUTZ, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 211 - 217
  • [34] Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy
    Sato, Yukina
    Iihara, Hirotoshi
    Kinomura, Motohiko
    Hirose, Chiemi
    Fujii, Hironori
    Endo, Junki
    Yanase, Komei
    Kaito, Daizo
    Sasaki, Yuka
    Gomyo, Takenobu
    Sakai, Chizuru
    Iwai, Masamichi
    Tsuboi, Yoshiki
    Ishihara, Takuma
    Kobayashi, Ryo
    Ohno, Yasushi
    Suzuki, Akio
    [J]. ANTICANCER RESEARCH, 2021, 41 (03) : 1615 - 1620
  • [35] Effect of meropenem with or without immunoglobulin as second-line therapy for pediatric febrile neutropenia
    Kobayashi, Ryoji
    Suzuki, Daisuke
    Sano, Hirozumi
    Kishimoto, Kenji
    Yasuda, Kazue
    Kobayashi, Kunihiko
    [J]. PEDIATRICS INTERNATIONAL, 2014, 56 (04) : 526 - 529
  • [36] EMPIRICAL ANTIMICROBIAL THERAPY WITH TIMENTIN PLUS AMIKACIN IN FEBRILE GRANULOCYTOPENIC CANCER-PATIENTS
    MEUNIER, F
    SNOECK, R
    LAGAST, H
    WOUSSEN, F
    KLASTERSKY, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 : 195 - 201
  • [37] Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients
    Kobayashi, Ryoji
    Hori, Daiki
    Sano, Hirozumi
    Suzuki, Daisuke
    Kishimoto, Kenji
    Kobayashi, Kunihiko
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2018, 51 (04) : 473 - 477
  • [38] HYPOPROTHROMBINEMIA IN FEBRILE, NEUTROPENIC PATIENTS WITH CANCER - ASSOCIATION WITH ANTIMICROBIAL SUPPRESSION OF INTESTINAL MICROFLORA
    CONLY, JM
    RAMOTAR, K
    CHUBB, H
    BOW, EJ
    LOUIE, TJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (02): : 202 - 212
  • [39] The role of anthracyclines in second-line therapy of ovarian cancer
    Vermorken, JB
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 : 178 - 184
  • [40] A new approach to second-line therapy for urothelial cancer?
    Galsky, Matthew D.
    Oh, William K.
    [J]. LANCET ONCOLOGY, 2013, 14 (08): : 682 - 684
12345